Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

J Rosing, S Middeldorp, J Curvers, MCL GDlig… - The Lancet, 1999 - thelancet.com
Background We have reported previously that, compared with use of second-generation oral
contraceptives, the use of third-generation oral contraceptives is associated with increased …
被引用次数：345 相关文章

[引用][C] Low-dose oral contraceptives and acquired resistance to activated protein C: a randomized cross-over study

J ROSING - Lancet, 1999 - cir.nii.ac.jp
Low-dose oral contraceptives and acquired resistance to activated protein C : a randomized
cross-over study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

J Rosing, S Middeldorp, J Curvers, MCL GDlig… - The Lancet, 1999 - thelancet.com
Background We have reported previously that, compared with use of second-generation oral
contraceptives, the use of third-generation oral contraceptives is associated with increased …

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

J Rosing, S Middeldorp, J Curvers… - …, 1999 - researchinformation.amsterdamumc …
BACKGROUND: We have reported previously that, compared with use of second-generation
oral contraceptives, the use of third-generation oral contraceptives is associated with …

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

J Rosing, S Middeldorp, J Curvers… - Lancet (London …, 1999 - pubmed.ncbi.nlm.nih.gov
Background We have reported previously that, compared with use of second-generation oral
contraceptives, the use of third-generation oral contraceptives is associated with increased …

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

J Rosing, S Middeldorp, J Curvers, MCL GDlig… - The Lancet, 1999 - Elsevier
BACKGROUND: We have reported previously that, compared with use of second-generation
oral contraceptives, the use of third-generation oral contraceptives is associated with …

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

J Rosing, S Middeldorp, J Curvers, M Christella… - The Lancet, 1999 - hero.epa.gov
BACKGROUND: We have reported previously that, compared with use of second-generation
oral contraceptives, the use of third-generation oral contraceptives is associated with …

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.

J Rosing, S Middeldorp, J Curvers - The Lancet, 1999 - elibrary.ru
Presents the results of a study on low-dose oral contraceptives and acquired resistance to
activated protein C (APC). How the plasma of women who use oral contraceptives is more …

[引用][C] Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

J ROSING, S MIDDELDORP, J CURVERS… - Lancet (British …, 1999 - pascal-francis.inist.fr
Low-dose oral contraceptives and acquired resistance to activated protein C : a randomised
cross-over study CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.

J Rosing, S Middeldorp, J Curvers… - Lancet (London …, 1999 - europepmc.org
Background We have reported previously that, compared with use of second-generation oral
contraceptives, the use of third-generation oral contraceptives is associated with increased …